Search research articles
Contact Us
Filters
Showing results (781-790 of 786) with videos related to
Page
of 79
Sort By:
You have reached the last page of results.
This site can display upto 786 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 8, 2023
Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial
Emmanuel S Antonarakis, Se Hoon Park, Jeffrey C Goh, et al.
The Review of Scientific Instruments
|
September 3, 2020
Time-resolved resonant elastic soft x-ray scattering at Pohang Accelerator Laboratory X-ray Free Electron Laser
Hoyoung Jang, Hyeong-Do Kim, Minseok Kim, et al.
Anticancer Research
|
December 30, 2023
Treatment Patterns and Prognosis of Palliative Chemotherapy Combined With Targeting Agents in Patients With Unresectable Metastatic Colorectal Cancer: CHOICE, A Multicenter Longitudinal Observational Study
Jwa Hoon Kim, Yongjun Cha, Sang Joon Shin, et al.
Journal of Extracellular Vesicles
|
April 14, 2026
Proteomic Profiling of Human Extracellular Vesicles Reveals Diagnostic Biomarkers for Colon Adenocarcinoma
Yura Seo, Yoon Dae Han, Linda Bojmar, et al.
Nature
|
May 6, 2021
ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma
Ivana Yen, Frances Shanahan, Jeeyun Lee, et al.
Nephrology (Carlton, Vic.)
|
May 15, 2025
Non-Inferiority of Subcutaneous Efepoetin Alfa Compared to Methoxy Polyethylene Glycol-Epoetin Beta in Stage 3 or 4 CKD Patients: Insights From a Phase 3 Trial
Simon D Roger, Chew Ming Wong, Phisitt Vejakama, et al.
Page
of 79
Search research articles
Search
Showing results (781-790 of 786) with videos related to
Sort By:
Page
of 79
You have reached the last page of results.
This site can display upto 786 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 8, 2023
Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial
Emmanuel S Antonarakis, Se Hoon Park, Jeffrey C Goh, et al.
The Review of Scientific Instruments
|
September 3, 2020
Time-resolved resonant elastic soft x-ray scattering at Pohang Accelerator Laboratory X-ray Free Electron Laser
Hoyoung Jang, Hyeong-Do Kim, Minseok Kim, et al.
Anticancer Research
|
December 30, 2023
Treatment Patterns and Prognosis of Palliative Chemotherapy Combined With Targeting Agents in Patients With Unresectable Metastatic Colorectal Cancer: CHOICE, A Multicenter Longitudinal Observational Study
Jwa Hoon Kim, Yongjun Cha, Sang Joon Shin, et al.
Journal of Extracellular Vesicles
|
April 14, 2026
Proteomic Profiling of Human Extracellular Vesicles Reveals Diagnostic Biomarkers for Colon Adenocarcinoma
Yura Seo, Yoon Dae Han, Linda Bojmar, et al.
Nature
|
May 6, 2021
ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma
Ivana Yen, Frances Shanahan, Jeeyun Lee, et al.
Nephrology (Carlton, Vic.)
|
May 15, 2025
Non-Inferiority of Subcutaneous Efepoetin Alfa Compared to Methoxy Polyethylene Glycol-Epoetin Beta in Stage 3 or 4 CKD Patients: Insights From a Phase 3 Trial
Simon D Roger, Chew Ming Wong, Phisitt Vejakama, et al.
Page
of 79